Xarelto (Rivaroxaban) Bleeding (US): Settlement Amounts

closed

United States case record · Last verified: 2026-09-01

Reported amounts & case results

Global MDL settlement: $775 million (per public reports, 2020). Common benefit fees of $93 million approved on March 23, 2020 (per court orders and reports). MDL 2592 formally closed Feb 11, 2026 (per JPML statistics report). Individual claim amounts varied under the settlement program; no amount can be promised.

Figures are as reported by the cited sources — not a promise of any individual outcome.

Reported amounts are what sources say — not a promise. Individual results depend on injuries, jurisdiction, and the stage of the case. This is not legal advice.

What affects case value

Injury severity — the single largest driver across mass torts.
Jurisdiction — national/state/provincial law (e.g., discovery rules, statute of limitations) can change outcomes.
Case stage — early filings and post-bellwether values differ.
Documentation — medical records and the exposure timeline.

Estimate your situation

See whether your case compares to documented outcomes. Free, no obligation.

Start free case review →